
|Articles|May 28, 2017
Kevzara Approval for RA Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
2
Pharmacists Can Close the LDL Control Gap in Lipid Care
3
Predictive Models Could Address Missing Data in Advanced Prostate Cancer
4
Ivonescimab Significantly Extends OS Over Pembrolizumab in PD-L1-Positive Advanced NSCLC
5




































































































